Compounds > rhodamine 123
Page last updated: 2024-08-24

rhodamine 123 and moxidectin

rhodamine 123 has been researched along with moxidectin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, A; Gao, J; Li, C; Liang, H; Shuang, B; Wang, Q; Wang, X; Xiang, W; Yan, Y; Zhang, J1
Gao, A; Jing, M; Liang, H; Wang, X; Xiang, W; Yan, Y; Zhang, J; Zhang, X1

Other Studies

2 other study(ies) available for rhodamine 123 and moxidectin

ArticleYear
Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
    Toxicology in vitro : an international journal published in association with BIBRA, 2010, Volume: 24, Issue:6

    Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Down-Regulation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Fluorescent Dyes; Gene Expression Regulation, Neoplastic; Humans; Macrolides; Rhodamine 123

2010
Reversal effects of two new milbemycin compounds on multidrug resistance in MCF-7/adr cells in vitro.
    European journal of pharmacology, 2011, Jun-01, Volume: 659, Issue:2-3

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Intracellular Space; Macrolides; Rhodamine 123

2011